A GUIDE TO UNDERSTANDING & SUPPORT

Internuclear ophthalmoplegia

Internuclear ophthalmoplegia, or INO, is an eye-movement pattern caused by disruption of a coordinating brainstem pathway. This guide explains its possible visual effects, causes, examination and the distinction between measured eye-motion changes and useful everyday improvement.

A brainstem connection between eye-movement centers can fail, making the two eyes move out of step.

Sources checked 24 Oct 2026Clinical review pendingEditorial sources
Explore the visual example
Sudden eye-movement change can be a stroke sign Sudden double vision, new difficulty coordinating eye movements, severe imbalance, weakness or speech changes requires urgent emergency assessment. Do not presume a new episode is multiple sclerosis or an old eye problem without assessment; INO has several causes. [1] [2]
EXPERIENCE, THEN EXPLAIN

Explore the visual exampleVisual example

VisualSim illustration

Adjust selected symptom features for discussion. Read the limits beside the controls. [1] [4]

A limited example of selected symptoms. It cannot identify this condition. [1] [4]

An example is already enabled. Adjust the controls to describe your experience.

Original clinic illustration. The interactive symptom example loads when graphics are available.
OriginalIllustrative view

Adjust this symptom example3 relevant settings
Relevant illustration controls

Double vision (diplopia)

45
22
0

Optional doubling can communicate a selected symptomatic viewing position. It does not reproduce inter-eye timing, nystagmus, convergence or an MLF lesion; a static scene may miss the main difficulty.

01 / THE QUICK EXPLANATION

Understanding Internuclear ophthalmoplegia

INO affects the medial longitudinal fasciculus, a nerve-fiber pathway linking horizontal gaze centers. One eye can move inward too slowly during a sideways gaze while the other moves outward with an oscillation. It can affect one or both sides; the pattern is named for the side with impaired inward movement. [1]

Some people notice double vision, visual instability or difficulty tracking moving targets, while subtle abnormalities may be found mainly on examination. Stroke and multiple sclerosis are important causes, but trauma, inflammation, infection and other disorders can also affect the pathway. Age and one-sided versus two-sided involvement are clues, not diagnostic rules. [2] [4]

02 / WHAT PEOPLE MAY EXPERIENCE

One condition. Different experiences.

Original VisualSim schematic illustrations, informed by the cited clinical descriptions. These are not study figures, patient recordings or validated severity levels.

Doubling during sideways gaze

Images may separate when looking to one side because the eyes are no longer moving together. Straight-ahead viewing can be less affected, depending on the associated alignment. [1]

Unstable or difficult tracking

The outward-moving eye may show nystagmus and the person may find following a target uncomfortable or unstable. Not every visible movement produces the same perceived world motion. [1] [4]

Additional vertical symptoms

Skew deviation or other brainstem findings can accompany INO, adding vertical or tilted images and imbalance. These associated findings change the assessment and functional burden. [1] [2]

The horizontal gaze connection

Original anatomical schematic; variation and associated findings prevent diagnosis from a screen example. [1] [6]

Original VisualSim teaching diagram · © VisualSim. Clinical basis in linked sources; not a published study figure. Image provenance.
  1. Gaze command

    One eye turns outward as the other turns inward.

  2. Internuclear link

    MLF fibers coordinate the opposite inward-moving eye.

  3. Disrupted timing

    A lesion can slow inward movement and produce associated outward-eye oscillation.

03 / WHAT WE KNOW

What is happening—and what remains uncertain

For a horizontal gaze shift, one eye turns outward and the other inward. Internuclear fibers connect the outward-movement nucleus on one side to the inward-movement subnucleus on the other through the MLF. A lesion disrupts their coordination even though this is not simply an isolated third or sixth nerve palsy. [1]

Convergence may be better preserved than sideways inward movement, but this is not an absolute rule for every lesion. In multiple sclerosis, slowed signaling through affected pathways is one research target; in stroke, the lesion and associated neurological injury determine the wider care needs. A similar-looking pseudo-INO can also occur from other mechanisms. [2] [3] [6]

04 / MAKING DISTINCTIONS

What can look similar?

INO versus isolated nerve palsy

A third nerve palsy can impair inward movement but often has a different combination of movement, lid and pupil findings. INO is a coordination-pathway sign, not another name for a weak medial rectus. [1] [6]

Pseudo-INO

Myasthenia and some other disorders can resemble parts of the pattern without the same MLF lesion. Variability and additional tests help distinguish the mechanism. [2] [6]

One-and-a-half and bilateral variants

Combining INO with a same-side horizontal gaze palsy produces one-and-a-half syndrome. Some bilateral cases have an outward resting deviation called WEBINO; these labels describe additional findings, not a severity score. [6]

Similar-looking symptoms can have different causes. A matching picture cannot establish a diagnosis.

05 / GETTING AN ASSESSMENT

What an assessment may involve

  1. Examine speed and coordinationThe examiner observes rapid horizontal gaze shifts, inward movement, outward-eye oscillation, alignment and convergence. A small speed difference may be missed by judging a static photograph alone. [1] [3]
  2. Locate the causeNeurological examination and appropriately selected MRI or other investigations evaluate the brainstem and possible causes. A clinical pattern does not by itself diagnose multiple sclerosis. [2] [6]
  3. Measure function and associated findingsAssessment includes vision, pupils, other movement abnormalities, vertical alignment and the activities that provoke symptoms. Reading, tracking and balance may need separate discussion. [1] [4]
06 / CARE AND UNCERTAINTY

What may help—and what is still being studied

Treat the underlying disorder

Acute stroke pathways, multiple-sclerosis management or another cause-specific plan take priority over cosmetic appearance of the eye movements. Recovery and follow-up depend on the mechanism and associated injury. [2] [6]

Relieve persistent visual symptoms

Selected patients may benefit from professionally prescribed prism, supervised occlusion or specialist alignment treatment. A method helping straight-ahead diplopia may not normalize coordinated movement in every direction. [4] [6]

Interpret drug research cautiously

A small fampridine trial in MS-related INO improved recorded saccadic coordination, but it did not establish durable everyday benefit for all INO. Specialist prescribing requires safety assessment; the trial is not a self-treatment recommendation. [3]

07 / DAILY LIFE

What this can mean for daily life

Describe the direction

Record which gaze shift, target or reading task provokes trouble. This helps distinguish a static alignment problem from symptoms mainly during eye movement. [1] [4]

Discuss fatigue and environment

For MS-associated symptoms, heat or fatigue can change the experience. Tell the team about variability without assuming it excludes another new problem. [4]

Get practical rehabilitation

Orthoptic and rehabilitation advice can address reading position, movement demands and safe activity after stroke or brain injury. Adaptations should fit the person’s actual deficits. [7]

Find cause-relevant peer support

MS community support is relevant when MS is established; broader sight support may help persistent difficulties from other causes. Shared experience is useful but does not substitute for assessment or establish prognosis. [4] [7]

08 / YOUR NEXT CONVERSATION

Bring a clearer description to your appointment

Choose the questions you want to discuss. These choices stay in this page’s memory.

09 / LOOK CLOSER

Research, with the context left in

Selected studies and guidance, with their populations and limitations. These are curated educational summaries, not a complete systematic review or a formal evidence rating.

2005 · Single-examiner inpatient case series accumulated over 33 years.

Internuclear ophthalmoplegia: unusual causes in 114 of 410 patients

Stroke and multiple sclerosis were common, but 114/410 had other causes. [2]

Limits and applicability: Historical selected inpatients, not population prevalence or a diagnostic probability for a current individual.

2019 · Randomized double-blind placebo-controlled crossover experiment; 24 completed and 23 analyzed.

Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine

A single-dose experiment improved recorded saccadic eye-movement measures; dizziness was frequent. [3]

Limits and applicability: Short-term physiological outcome in MS-related INO, not durable daily-life, reading or disease-modification evidence; it does not apply to every cause.

2002 · Multicenter retrospective series of 33 people with ischemic INO.

Prognosis of ischemic internuclear ophthalmoplegia

Many regained single vision in primary position; associated neurological signs were linked to less favorable resolution. [5]

Limits and applicability: The outcome was primary-position diplopia, not complete eye-movement normalization. Small historical series cannot guarantee an individual timeline.

Questions researchers still need to answer
  • Which eye-movement measures best predict changes that patients notice in daily life?
  • Which persistent INO patterns benefit from targeted symptom treatment after cause-specific care?
10 / KEEP LEARNING

Trusted places to go next

Selected clinical references, research, practical support and ways to connect. Official pages checked 24 October 2026; each entry explains its scope and region.

Charity & support · UK-based MS support; public education worldwide

MS Society: eyes, sight and community

Relevant when the eye-movement problem is associated with multiple sclerosis. Information and organization-linked peer forum; forum experiences are not medical advice and INO does not by itself diagnose MS.

Connections listed by the organization.

Peer connection · UK; regional groups and UK support services

RNIB community connection and wellbeing

Broader peer connection for people affected by persistent sight difficulties and their families; not a condition-specific group or medical advice. Check each service’s geographic eligibility.

Connections listed by the organization.

Clinical education · US academic education; public access worldwide

University of Iowa INO atlas

Explains the pathway with a clinical example; a case image is not a diagnostic matching test.

Vision rehabilitation · UK and Ireland professional information

British and Irish Orthoptic Society: stroke or brain injury

Useful when INO follows stroke or brain injury; describes orthoptic assessment and practical support.

11 / COMMON QUESTIONS

Questions you may still have

Does INO mean I have multiple sclerosis?

No. MS is one cause, but stroke and a range of other disorders can disrupt the same pathway. [2]

Is one eye simply paralyzed?

INO primarily describes failed coordination through an internuclear pathway; its characteristic movement pattern differs from an isolated peripheral nerve palsy. [1]

Will normal straight-ahead vision mean everything has recovered?

Not necessarily. Single vision in primary position and normal speed or coordination in other gazes are different outcomes. [3] [5]

Does fampridine cure INO?

No such conclusion follows from the small short-term trial. It measured eye movements in selected MS patients and requires specialist interpretation and safety assessment. [3]

12 / TRANSPARENCY

Sources, image credits and review status

Compiled by VisualSim from clinical references and published research. Sources checked 24 October 2026. Independent clinical review has not been recorded; no named clinical reviewer or clinical validation is claimed. Research evidence and its limitations are linked below.

  1. University of Iowa EyeRounds: Internuclear ophthalmoplegia atlas (n.d.; institution).

    Opened the relevant source text; educational material, not independent clinical review.

    Checked 2026-10-24 · Public page checked
  2. Keane: Internuclear ophthalmoplegia: unusual causes in 114 of 410 patients (2005; observational).

    Original indexed abstract checked; study is a historical inpatient series.

    Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed
  3. Kanhai and colleagues: Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine (2019; trial).

    Institutional abstract and indexed original PDF methods/results checked; single-dose crossover and analyzed-versus-completed sample distinguished.

    Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed
  4. MS Society: MS eye and vision problems (n.d.; institution).

    Opened INO, symptoms, living support and organization-linked forum; broader treatment wording is not applied to every cause.

    Checked 2026-10-24 · Public page checked
  5. Eggenberger and colleagues: Prognosis of ischemic internuclear ophthalmoplegia (2002; observational).

    Original publisher abstract checked; outcome is primary-position diplopia.

    Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed
  6. Dinkin: Diagnostic approach to diplopia (2014; review).

    Indexed original anatomical and differential discussion checked.

    Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed
  7. British and Irish Orthoptic Society: Stroke or brain injury (n.d.; institution).

    Opened the relevant source text; educational material, not independent clinical review.

    Checked 2026-10-24 · Public page checked

The simulator helps people communicate an experience. It cannot diagnose a condition, measure a visual field, or establish that someone is safe to drive.

Enlarged figure